Sunjeet S.

A digital wealth app providing a financial ecosystem for you to get advice, plan, save, and invest all in the palm of your hand.

A digital wealth app providing a financial ecosystem for you to get advice, plan, save, and invest all in the palm of your hand.

Maroon Venture Fund I LP (launched by Maroon Invest Global) invests anchor venture capital (Seed to Series B) to advance HEALTHY LONGEVITY by utilising proactive, personalised Precision Medicine & Preventative Health innovation to accelerate protocols, diagnostics, and therapeutics to prevent and/or provide early treatment for chronic Population Health conditions; as well as, direct Climate Impact on Health. Healthy Longevity Science areas are focused on: - Neurological & Brain Health - Autoimmune Disorders (incl. Diabetes, Inflammation) - Cardiovascular & Blood Health - Direct Climate-Health areas (incl. respiratory health, exposomes) Demographics include: - Children & Womens Health - Mens Health - High Performance groups

Shire acquired Baxalta on June 3, 2016. Following this date, this page will no longer be actively monitored. There will be no updates or responses posted on this page. For continued news and updates, we encourage you to follow Shire on LinkedIn at https://www.linkedin.com/company/shire

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation